Leptin Receptor
The research report includes specific segments by region (country), by company, by Type and by Ap ... Read More
Global Receptor Tyrosine Protein Kinase Targeted Drugs Market Research Report 2024
1 Receptor Tyrosine Protein Kinase Targeted Drugs Market Overview
1.1 Product Overview and Scope of Receptor Tyrosine Protein Kinase Targeted Drugs
1.2 Receptor Tyrosine Protein Kinase Targeted Drugs Segment by Type
1.2.1 Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales Growth Rate Comparison by Type (2022-2028)
1.2.2 Afatinib Dimaleate
1.2.3 Dacomitinib
1.2.4 Neratinib
1.2.5 Neucardin
1.2.6 Others
1.3 Receptor Tyrosine Protein Kinase Targeted Drugs Segment by Application
1.3.1 Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales Comparison by Application: (2022-2028)
1.3.2 Oncology
1.3.3 Cardiovascular
1.3.4 Central Nervous System
1.3.5 Others
1.4 Global Receptor Tyrosine Protein Kinase Targeted Drugs Market Size Estimates and Forecasts
1.4.1 Global Receptor Tyrosine Protein Kinase Targeted Drugs Revenue 2017-2028
1.4.2 Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales 2017-2028
1.4.3 Receptor Tyrosine Protein Kinase Targeted Drugs Market Size by Region: 2017 Versus 2021 Versus 2028
2 Receptor Tyrosine Protein Kinase Targeted Drugs Market Competition by Manufacturers
2.1 Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share by Manufacturers (2017-2022)
2.2 Global Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Market Share by Manufacturers (2017-2022)
2.3 Global Receptor Tyrosine Protein Kinase Targeted Drugs Average Price by Manufacturers (2017-2022)
2.4 Manufacturers Receptor Tyrosine Protein Kinase Targeted Drugs Manufacturing Sites, Area Served, Product Type
2.5 Receptor Tyrosine Protein Kinase Targeted Drugs Market Competitive Situation and Trends
2.5.1 Receptor Tyrosine Protein Kinase Targeted Drugs Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Receptor Tyrosine Protein Kinase Targeted Drugs Players Market Share by Revenue
2.5.3 Global Receptor Tyrosine Protein Kinase Targeted Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Receptor Tyrosine Protein Kinase Targeted Drugs Retrospective Market Scenario by Region
3.1 Global Receptor Tyrosine Protein Kinase Targeted Drugs Retrospective Market Scenario in Sales by Region: 2017-2022
3.2 Global Receptor Tyrosine Protein Kinase Targeted Drugs Retrospective Market Scenario in Revenue by Region: 2017-2022
3.3 North America Receptor Tyrosine Protein Kinase Targeted Drugs Market Facts & Figures by Country
3.3.1 North America Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Country
3.3.2 North America Receptor Tyrosine Protein Kinase Targeted Drugs Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Receptor Tyrosine Protein Kinase Targeted Drugs Market Facts & Figures by Country
3.4.1 Europe Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Country
3.4.2 Europe Receptor Tyrosine Protein Kinase Targeted Drugs Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Receptor Tyrosine Protein Kinase Targeted Drugs Market Facts & Figures by Region
3.5.1 Asia Pacific Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Region
3.5.2 Asia Pacific Receptor Tyrosine Protein Kinase Targeted Drugs Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Receptor Tyrosine Protein Kinase Targeted Drugs Market Facts & Figures by Country
3.6.1 Latin America Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Country
3.6.2 Latin America Receptor Tyrosine Protein Kinase Targeted Drugs Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Receptor Tyrosine Protein Kinase Targeted Drugs Market Facts & Figures by Country
3.7.1 Middle East and Africa Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Country
3.7.2 Middle East and Africa Receptor Tyrosine Protein Kinase Targeted Drugs Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Receptor Tyrosine Protein Kinase Targeted Drugs Historic Market Analysis by Type
4.1 Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share by Type (2017-2022)
4.2 Global Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Market Share by Type (2017-2022)
4.3 Global Receptor Tyrosine Protein Kinase Targeted Drugs Price by Type (2017-2022)
5 Global Receptor Tyrosine Protein Kinase Targeted Drugs Historic Market Analysis by Application
5.1 Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share by Application (2017-2022)
5.2 Global Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Market Share by Application (2017-2022)
5.3 Global Receptor Tyrosine Protein Kinase Targeted Drugs Price by Application (2017-2022)
6 Key Companies Profiled
6.1 Aslan Pharmaceuticals Pte Ltd
6.1.1 Aslan Pharmaceuticals Pte Ltd Corporation Information
6.1.2 Aslan Pharmaceuticals Pte Ltd Description and Business Overview
6.1.3 Aslan Pharmaceuticals Pte Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Sales, Revenue and Gross Margin (2017-2022)
6.1.4 Aslan Pharmaceuticals Pte Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Product Portfolio
6.1.5 Aslan Pharmaceuticals Pte Ltd Recent Developments/Updates
6.2 Boehringer Ingelheim GmbH
6.2.1 Boehringer Ingelheim GmbH Corporation Information
6.2.2 Boehringer Ingelheim GmbH Description and Business Overview
6.2.3 Boehringer Ingelheim GmbH Receptor Tyrosine Protein Kinase Targeted Drugs Sales, Revenue and Gross Margin (2017-2022)
6.2.4 Boehringer Ingelheim GmbH Receptor Tyrosine Protein Kinase Targeted Drugs Product Portfolio
6.2.5 Boehringer Ingelheim GmbH Recent Developments/Updates
6.3 GamaMabs Pharma SA
6.3.1 GamaMabs Pharma SA Corporation Information
6.3.2 GamaMabs Pharma SA Description and Business Overview
6.3.3 GamaMabs Pharma SA Receptor Tyrosine Protein Kinase Targeted Drugs Sales, Revenue and Gross Margin (2017-2022)
6.3.4 GamaMabs Pharma SA Receptor Tyrosine Protein Kinase Targeted Drugs Product Portfolio
6.3.5 GamaMabs Pharma SA Recent Developments/Updates
6.4 Hanmi Pharmaceuticals Co Ltd
6.4.1 Hanmi Pharmaceuticals Co Ltd Corporation Information
6.4.2 Hanmi Pharmaceuticals Co Ltd Description and Business Overview
6.4.3 Hanmi Pharmaceuticals Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Hanmi Pharmaceuticals Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Product Portfolio
6.4.5 Hanmi Pharmaceuticals Co Ltd Recent Developments/Updates
6.5 Jiangsu Kanion Pharmaceutical Co Ltd
6.5.1 Jiangsu Kanion Pharmaceutical Co Ltd Corporation Information
6.5.2 Jiangsu Kanion Pharmaceutical Co Ltd Description and Business Overview
6.5.3 Jiangsu Kanion Pharmaceutical Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Sales, Revenue and Gross Margin (2017-2022)
6.5.4 Jiangsu Kanion Pharmaceutical Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Product Portfolio
6.5.5 Jiangsu Kanion Pharmaceutical Co Ltd Recent Developments/Updates
6.6 Minerva Neurosciences Inc
6.6.1 Minerva Neurosciences Inc Corporation Information
6.6.2 Minerva Neurosciences Inc Description and Business Overview
6.6.3 Minerva Neurosciences Inc Receptor Tyrosine Protein Kinase Targeted Drugs Sales, Revenue and Gross Margin (2017-2022)
6.6.4 Minerva Neurosciences Inc Receptor Tyrosine Protein Kinase Targeted Drugs Product Portfolio
6.6.5 Minerva Neurosciences Inc Recent Developments/Updates
6.7 Pfizer Inc
6.6.1 Pfizer Inc Corporation Information
6.6.2 Pfizer Inc Description and Business Overview
6.6.3 Pfizer Inc Receptor Tyrosine Protein Kinase Targeted Drugs Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Pfizer Inc Receptor Tyrosine Protein Kinase Targeted Drugs Product Portfolio
6.7.5 Pfizer Inc Recent Developments/Updates
6.8 Puma Biotechnology Inc
6.8.1 Puma Biotechnology Inc Corporation Information
6.8.2 Puma Biotechnology Inc Description and Business Overview
6.8.3 Puma Biotechnology Inc Receptor Tyrosine Protein Kinase Targeted Drugs Sales, Revenue and Gross Margin (2017-2022)
6.8.4 Puma Biotechnology Inc Receptor Tyrosine Protein Kinase Targeted Drugs Product Portfolio
6.8.5 Puma Biotechnology Inc Recent Developments/Updates
6.9 Shanghai Fosun Pharmaceutical (Group) Co Ltd
6.9.1 Shanghai Fosun Pharmaceutical (Group) Co Ltd Corporation Information
6.9.2 Shanghai Fosun Pharmaceutical (Group) Co Ltd Description and Business Overview
6.9.3 Shanghai Fosun Pharmaceutical (Group) Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Sales, Revenue and Gross Margin (2017-2022)
6.9.4 Shanghai Fosun Pharmaceutical (Group) Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Product Portfolio
6.9.5 Shanghai Fosun Pharmaceutical (Group) Co Ltd Recent Developments/Updates
6.10 XuanZhu Pharma Co Ltd
6.10.1 XuanZhu Pharma Co Ltd Corporation Information
6.10.2 XuanZhu Pharma Co Ltd Description and Business Overview
6.10.3 XuanZhu Pharma Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Sales, Revenue and Gross Margin (2017-2022)
6.10.4 XuanZhu Pharma Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Product Portfolio
6.10.5 XuanZhu Pharma Co Ltd Recent Developments/Updates
6.11 Zensun (Shanghai) Sci & Tech Co Ltd
6.11.1 Zensun (Shanghai) Sci & Tech Co Ltd Corporation Information
6.11.2 Zensun (Shanghai) Sci & Tech Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Description and Business Overview
6.11.3 Zensun (Shanghai) Sci & Tech Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Sales, Revenue and Gross Margin (2017-2022)
6.11.4 Zensun (Shanghai) Sci & Tech Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Product Portfolio
6.11.5 Zensun (Shanghai) Sci & Tech Co Ltd Recent Developments/Updates
7 Receptor Tyrosine Protein Kinase Targeted Drugs Manufacturing Cost Analysis
7.1 Receptor Tyrosine Protein Kinase Targeted Drugs Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Receptor Tyrosine Protein Kinase Targeted Drugs
7.4 Receptor Tyrosine Protein Kinase Targeted Drugs Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Receptor Tyrosine Protein Kinase Targeted Drugs Distributors List
8.3 Receptor Tyrosine Protein Kinase Targeted Drugs Customers
9 Receptor Tyrosine Protein Kinase Targeted Drugs Market Dynamics
9.1 Receptor Tyrosine Protein Kinase Targeted Drugs Industry Trends
9.2 Receptor Tyrosine Protein Kinase Targeted Drugs Market Drivers
9.3 Receptor Tyrosine Protein Kinase Targeted Drugs Market Challenges
9.4 Receptor Tyrosine Protein Kinase Targeted Drugs Market Restraints
10 Global Market Forecast
10.1 Receptor Tyrosine Protein Kinase Targeted Drugs Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Receptor Tyrosine Protein Kinase Targeted Drugs by Type (2023-2028)
10.1.2 Global Forecasted Revenue of Receptor Tyrosine Protein Kinase Targeted Drugs by Type (2023-2028)
10.2 Receptor Tyrosine Protein Kinase Targeted Drugs Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Receptor Tyrosine Protein Kinase Targeted Drugs by Application (2023-2028)
10.2.2 Global Forecasted Revenue of Receptor Tyrosine Protein Kinase Targeted Drugs by Application (2023-2028)
10.3 Receptor Tyrosine Protein Kinase Targeted Drugs Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Receptor Tyrosine Protein Kinase Targeted Drugs by Region (2023-2028)
10.3.2 Global Forecasted Revenue of Receptor Tyrosine Protein Kinase Targeted Drugs by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales Growth Rate Comparison by Type (2022-2028) & (K Pcs) & (US$ Million)
Table 2. Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales Growth Rate Comparison by Application (2022-2028) & (K Pcs) & (US$ Million)
Table 3. Global Receptor Tyrosine Protein Kinase Targeted Drugs Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
Table 4. Global Receptor Tyrosine Protein Kinase Targeted Drugs Market Competitive Situation by Manufacturers in 2021
Table 5. Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs) of Key Manufacturers (2017-2022)
Table 6. Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share by Manufacturers (2017-2022)
Table 7. Global Receptor Tyrosine Protein Kinase Targeted Drugs Revenue (US$ Million) by Manufacturers (2017-2022)
Table 8. Global Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Share by Manufacturers (2017-2022)
Table 9. Global Market Receptor Tyrosine Protein Kinase Targeted Drugs Average Price (USD/Pcs) of Key Manufacturers (2017-2022)
Table 10. Manufacturers Receptor Tyrosine Protein Kinase Targeted Drugs Manufacturing Sites and Area Served
Table 11. Manufacturers Receptor Tyrosine Protein Kinase Targeted Drugs Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Receptor Tyrosine Protein Kinase Targeted Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Receptor Tyrosine Protein Kinase Targeted Drugs as of 2021)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Region (2017-2022) & (K Pcs)
Table 16. Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share by Region (2017-2022)
Table 17. Global Receptor Tyrosine Protein Kinase Targeted Drugs Revenue by Region (2017-2022) & (US$ Million)
Table 18. Global Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Market Share by Region (2017-2022)
Table 19. North America Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Country (2017-2022) & (K Pcs)
Table 20. North America Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share by Country (2017-2022)
Table 21. North America Receptor Tyrosine Protein Kinase Targeted Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 22. North America Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Market Share by Country (2017-2022)
Table 23. Europe Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Country (2017-2022) & (K Pcs)
Table 24. Europe Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share by Country (2017-2022)
Table 25. Europe Receptor Tyrosine Protein Kinase Targeted Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 26. Europe Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Market Share by Country (2017-2022)
Table 27. Asia Pacific Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Region (2017-2022) & (K Pcs)
Table 28. Asia Pacific Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share by Region (2017-2022)
Table 29. Asia Pacific Receptor Tyrosine Protein Kinase Targeted Drugs Revenue by Region (2017-2022) & (US$ Million)
Table 30. Asia Pacific Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Market Share by Region (2017-2022)
Table 31. Latin America Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Country (2017-2022) & (K Pcs)
Table 32. Latin America Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share by Country (2017-2022)
Table 33. Latin America Receptor Tyrosine Protein Kinase Targeted Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 34. Latin America Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Market Share by Country (2017-2022)
Table 35. Middle East and Africa Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Country (2017-2022) & (K Pcs)
Table 36. Middle East and Africa Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share by Country (2017-2022)
Table 37. Middle East and Africa Receptor Tyrosine Protein Kinase Targeted Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 38. Middle East and Africa Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Market Share by Country (2017-2022)
Table 39. Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Type (2017-2022) & (K Pcs)
Table 40. Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share by Type (2017-2022)
Table 41. Global Receptor Tyrosine Protein Kinase Targeted Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 42. Global Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Share by Type (2017-2022)
Table 43. Global Receptor Tyrosine Protein Kinase Targeted Drugs Price by Type (2017-2022) & (USD/Pcs)
Table 44. Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs) by Application (2017-2022)
Table 45. Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share by Application (2017-2022)
Table 46. Global Receptor Tyrosine Protein Kinase Targeted Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 47. Global Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Share by Application (2017-2022)
Table 48. Global Receptor Tyrosine Protein Kinase Targeted Drugs Price by Application (2017-2022) & (USD/Pcs)
Table 49. Aslan Pharmaceuticals Pte Ltd Corporation Information
Table 50. Aslan Pharmaceuticals Pte Ltd Description and Business Overview
Table 51. Aslan Pharmaceuticals Pte Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 52. Aslan Pharmaceuticals Pte Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Product
Table 53. Aslan Pharmaceuticals Pte Ltd Recent Developments/Updates
Table 54. Boehringer Ingelheim GmbH Corporation Information
Table 55. Boehringer Ingelheim GmbH Description and Business Overview
Table 56. Boehringer Ingelheim GmbH Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 57. Boehringer Ingelheim GmbH Receptor Tyrosine Protein Kinase Targeted Drugs Product
Table 58. Boehringer Ingelheim GmbH Recent Developments/Updates
Table 59. GamaMabs Pharma SA Corporation Information
Table 60. GamaMabs Pharma SA Description and Business Overview
Table 61. GamaMabs Pharma SA Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 62. GamaMabs Pharma SA Receptor Tyrosine Protein Kinase Targeted Drugs Product
Table 63. GamaMabs Pharma SA Recent Developments/Updates
Table 64. Hanmi Pharmaceuticals Co Ltd Corporation Information
Table 65. Hanmi Pharmaceuticals Co Ltd Description and Business Overview
Table 66. Hanmi Pharmaceuticals Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 67. Hanmi Pharmaceuticals Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Product
Table 68. Hanmi Pharmaceuticals Co Ltd Recent Developments/Updates
Table 69. Jiangsu Kanion Pharmaceutical Co Ltd Corporation Information
Table 70. Jiangsu Kanion Pharmaceutical Co Ltd Description and Business Overview
Table 71. Jiangsu Kanion Pharmaceutical Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 72. Jiangsu Kanion Pharmaceutical Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Product
Table 73. Jiangsu Kanion Pharmaceutical Co Ltd Recent Developments/Updates
Table 74. Minerva Neurosciences Inc Corporation Information
Table 75. Minerva Neurosciences Inc Description and Business Overview
Table 76. Minerva Neurosciences Inc Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 77. Minerva Neurosciences Inc Receptor Tyrosine Protein Kinase Targeted Drugs Product
Table 78. Minerva Neurosciences Inc Recent Developments/Updates
Table 79. Pfizer Inc Corporation Information
Table 80. Pfizer Inc Description and Business Overview
Table 81. Pfizer Inc Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 82. Pfizer Inc Receptor Tyrosine Protein Kinase Targeted Drugs Product
Table 83. Pfizer Inc Recent Developments/Updates
Table 84. Puma Biotechnology Inc Corporation Information
Table 85. Puma Biotechnology Inc Description and Business Overview
Table 86. Puma Biotechnology Inc Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 87. Puma Biotechnology Inc Receptor Tyrosine Protein Kinase Targeted Drugs Product
Table 88. Puma Biotechnology Inc Recent Developments/Updates
Table 89. Shanghai Fosun Pharmaceutical (Group) Co Ltd Corporation Information
Table 90. Shanghai Fosun Pharmaceutical (Group) Co Ltd Description and Business Overview
Table 91. Shanghai Fosun Pharmaceutical (Group) Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 92. Shanghai Fosun Pharmaceutical (Group) Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Product
Table 93. Shanghai Fosun Pharmaceutical (Group) Co Ltd Recent Developments/Updates
Table 94. XuanZhu Pharma Co Ltd Corporation Information
Table 95. XuanZhu Pharma Co Ltd Description and Business Overview
Table 96. XuanZhu Pharma Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 97. XuanZhu Pharma Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Product
Table 98. XuanZhu Pharma Co Ltd Recent Developments/Updates
Table 99. Zensun (Shanghai) Sci & Tech Co Ltd Corporation Information
Table 100. Zensun (Shanghai) Sci & Tech Co Ltd Description and Business Overview
Table 101. Zensun (Shanghai) Sci & Tech Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 102. Zensun (Shanghai) Sci & Tech Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Product
Table 103. Zensun (Shanghai) Sci & Tech Co Ltd Recent Developments/Updates
Table 104. Production Base and Market Concentration Rate of Raw Material
Table 105. Key Suppliers of Raw Materials
Table 106. Receptor Tyrosine Protein Kinase Targeted Drugs Distributors List
Table 107. Receptor Tyrosine Protein Kinase Targeted Drugs Customers List
Table 108. Receptor Tyrosine Protein Kinase Targeted Drugs Market Trends
Table 109. Receptor Tyrosine Protein Kinase Targeted Drugs Market Drivers
Table 110. Receptor Tyrosine Protein Kinase Targeted Drugs Market Challenges
Table 111. Receptor Tyrosine Protein Kinase Targeted Drugs Market Restraints
Table 112. Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales Forecast by Type (2023-2028) & (K Pcs)
Table 113. Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share Forecast by Type (2023-2028)
Table 114. Global Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Forecast by Type (2023-2028) & (US$ Million)
Table 115. Global Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Market Share Forecast by Type (2023-2028)
Table 116. Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales Forecast by Application (2023-2028) & (K Pcs)
Table 117. Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share Forecast by Application (2023-2028)
Table 118. Global Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Forecast by Application (2023-2028) & (US$ Million)
Table 119. Global Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Market Share Forecast by Application (2023-2028)
Table 120. Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales Forecast by Region (2023-2028) & (K Pcs)
Table 121. Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share Forecast by Region (2023-2028)
Table 122. Global Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 123. Global Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Market Share Forecast by Region (2023-2028)
Table 124. Research Programs/Design for This Report
Table 125. Key Data Information from Secondary Sources
Table 126. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Receptor Tyrosine Protein Kinase Targeted Drugs
Figure 2. Global Receptor Tyrosine Protein Kinase Targeted Drugs Market Share by Type in 2021 & 2028
Figure 3. Afatinib Dimaleate Product Picture
Figure 4. Dacomitinib Product Picture
Figure 5. Neratinib Product Picture
Figure 6. Neucardin Product Picture
Figure 7. Others Product Picture
Figure 8. Global Receptor Tyrosine Protein Kinase Targeted Drugs Market Share by Application in 2021 & 2028
Figure 9. Oncology
Figure 10. Cardiovascular
Figure 11. Central Nervous System
Figure 12. Others
Figure 13. Global Receptor Tyrosine Protein Kinase Targeted Drugs Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 14. Global Receptor Tyrosine Protein Kinase Targeted Drugs Market Size (2017-2028) & (US$ Million)
Figure 15. Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales (2017-2028) & (K Pcs)
Figure 16. Receptor Tyrosine Protein Kinase Targeted Drugs Sales Share by Manufacturers in 2021
Figure 17. Global Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Share by Manufacturers in 2021
Figure 18. The Global 5 and 10 Largest Receptor Tyrosine Protein Kinase Targeted Drugs Players: Market Share by Revenue in 2021
Figure 19. Receptor Tyrosine Protein Kinase Targeted Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 20. Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share by Region (2017-2022)
Figure 21. Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share by Region in 2021
Figure 22. Global Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Market Share by Region (2017-2022)
Figure 23. Global Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Market Share by Region in 2021
Figure 24. U.S. Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 25. Canada Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 26. Germany Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 27. France Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 28. U.K. Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 29. Italy Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 30. Russia Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 31. China Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 32. Japan Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 33. South Korea Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 34. India Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 35. Australia Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 36. Taiwan Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 37. Indonesia Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 38. Thailand Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 39. Malaysia Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 40. Philippines Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 41. Vietnam Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 42. Mexico Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 43. Brazil Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 44. Argentina Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 45. Turkey Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 46. Saudi Arabia Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 47. UAE Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 48. Sales Market Share of Receptor Tyrosine Protein Kinase Targeted Drugs by Type (2017-2022)
Figure 49. Manufacturing Cost Structure of Receptor Tyrosine Protein Kinase Targeted Drugs
Figure 50. Manufacturing Process Analysis of Receptor Tyrosine Protein Kinase Targeted Drugs
Figure 51. Receptor Tyrosine Protein Kinase Targeted Drugs Industrial Chain Analysis
Figure 52. Channels of Distribution
Figure 53. Distributors Profiles
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Aslan Pharmaceuticals Pte Ltd Boehringer Ingelheim GmbH GamaMabs Pharma SA Hanmi Pharmaceuticals Co Ltd Jiangsu Kanion Pharmaceutical Co Ltd Minerva Neurosciences Inc Pfizer Inc Puma Biotechnology Inc Shanghai Fosun Pharmaceutical (Group) Co Ltd XuanZhu Pharma Co Ltd Zensun (Shanghai) Sci & Tech Co Ltd